Compass Oncology Rose Quarter — Portland, Oregon

Compass Oncology Rose Quarter is a clinical research site located in Portland, Oregon, United States 97227.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Compass Oncology Rose Quarter has participated in 23 clinical trials with 9 currently active.

Therapeutic areas: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified.

Sponsors: GOG Foundation, Gynecologic Oncology Group, OHSU Knight Cancer Institute.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology Rose Quarter?

Compass Oncology Rose Quarter has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology Rose Quarter conducted?

Compass Oncology Rose Quarter has 23 clinical trials on record, with 9 currently active. Their work covers Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified.

Is Compass Oncology Rose Quarter accredited by Crixeo Health?

Yes — Compass Oncology Rose Quarter holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Compass Oncology Rose Quarter?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.